Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties
Open Access
- 18 December 2009
- journal article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 7 (1) , 109
Abstract
Optimization of the current dendritic cell (DC) culture protocol in order to promote the therapeutic efficacy of DC-based immunotherapy is warranted. Alternative differentiation of monocyte-derived DCs using granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-15 has been propagated as an attractive strategy in that regard. The applicability of these so-called IL-15 DCs has not yet been firmly established. We therefore developed a novel pre-clinical approach for the generation of IL-15 DCs with potent immunostimulatory properties.Keywords
This publication has 58 references indexed in Scilit:
- IL-15Rα chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentationJournal of Experimental Medicine, 2008
- Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migrationCancer Immunology, Immunotherapy, 2008
- Monocyte derived dendritic cells generated by IFN-α acquire mature dendritic and natural killer cell properties as shown by gene expression analysisJournal of Translational Medicine, 2007
- A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccinesBMC Cancer, 2007
- IL‐15‐induced human DC efficiently prime melanoma‐specific naive CD8+ T cells to differentiate into CTLEuropean Journal of Immunology, 2007
- Tolls and Beyond — Many Roads to Vaccine ImmunityNew England Journal of Medicine, 2007
- Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70Journal of Translational Medicine, 2007
- The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine designNature Reviews Immunology, 2006
- Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cellsNature Immunology, 2005
- IL-15-induced conversion of monocytes to mature dendritic cellsClinical and Experimental Immunology, 2001